Foamix Pharmaceuticals (FOMX +7%) is up on below-average volume on the heels of its announcement that acne treatment Amzeeq (minocycline) topical foam, 4% is now available in U.S. pharmacies for patients at least nine years old.
The FDA approved it in October 2019.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.